a public good project by the
Synthesis
Company
of California

© 2026

Andrew P. Keaveny | doi.page

0 works0 citations0 h-index

Andrew P. Keaveny

Jacksonville College(US)WinnMed(US)Foundation for Liver Research(GB)Mayo Clinic in Arizona(US)Mayo Clinic in Florida(US)Marshall University(US)

Publications by Year

Research Areas

Liver Disease and Transplantation, Organ Transplantation Techniques and Outcomes, Liver Disease Diagnosis and Treatment, Renal Transplantation Outcomes and Treatments, Hepatitis C virus research

Most-Cited Works

→ Diagnostic Performance of Magnetic Resonance Elastography in Staging Liver Fibrosis: A Systematic Review and Meta-analysis of Individual Participant Data(2014)533 cited
→ Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant(2015)180 cited
→ Global Burden of Digestive Diseases: A Systematic Analysis of the Global Burden of Diseases Study, 1990 to 2019(2023)171 cited
→ Liver transplantation using controlled donation after cardiac death donors: An analysis of a large single-center experience(2009)171 cited
→ Events in Procurement as Risk Factors for Ischemic Cholangiopathy in Liver Transplantation Using Donation After Cardiac Death Donors(2011)157 cited
→ Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements(2015)129 cited

→ Improving National Results in Liver Transplantation Using Grafts From Donation After Cardiac Death Donors(2016)120 cited

→ An Assessment of Digital Image Analysis to Measure Fibrosis in Liver Biopsy Specimens of Patients With Chronic Hepatitis C(2000)116 cited

→ Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation(2013)102 cited

→ Early Allograft Dysfunction After Liver Transplantation Is Associated With Short- and Long-Term Kidney Function Impairment(2015)89 cited